SODIUM POLYSTYRENE SULFONATE — all Canadian products
15 DINs
9 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is SODIUM POLYSTYRENE SULFONATE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02497557 | JAMP SODIUM POLYSTYRENE SULFONATE | JAMP PHARMA CORPORATION | Powder For Suspension | Oral; Rectal | SODIUM POLYSTYRENE SULFONATE 1 G | Marketed | |
| 02569701 | JAMP SODIUM POLYSTYRENE SULFONATE | JAMP PHARMA CORPORATION | Suspension | Oral | SODIUM POLYSTYRENE SULFONATE 250 MG | Approved | |
| 02026961 | KAYEXALATE | SANOFI-AVENTIS CANADA INC | Powder For Suspension | Oral; Rectal | SODIUM POLYSTYRENE SULFONATE 1 G | Marketed | |
| 02473968 | ODAN-SODIUM POLYSTYRENE SULFONATE | ODAN LABORATORIESLTD | Suspension | Oral; Rectal | SODIUM POLYSTYRENE SULFONATE 250 MG | Marketed | |
| 02473941 | ODAN-SODIUM POLYSTYRENE SULFONATE | ODAN LABORATORIESLTD | Powder For Suspension | Rectal; Oral | SODIUM POLYSTYRENE SULFONATE 1 G | Marketed | |
| 02501864 | PMS-SODIUM POLYSTYRENE SULFONATE | PHARMASCIENCE INC | Powder For Suspension | Oral; Rectal | SODIUM POLYSTYRENE SULFONATE 1 G | Approved | |
| 02501872 | PMS-SODIUM POLYSTYRENE SULFONATE | PHARMASCIENCE INC | Suspension | Oral | SODIUM POLYSTYRENE SULFONATE 250 MG | Approved | |
| 00755338 | SOLYSTAT | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Powder For Suspension | Rectal; Oral | SODIUM POLYSTYRENE SULFONATE 1 G | Marketed | |
| 00769541 | SOLYSTAT | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Suspension | Oral | SODIUM POLYSTYRENE SULFONATE 250 MG | Marketed | |
| 00765252 | K-EXIT POUDRE | OMEGA LABORATORIES LIMITED | Powder For Solution | Oral; Rectal | SODIUM POLYSTYRENE SULFONATE 100 % | Cancelled Post Market | |
| 02261650 | PHL-SODIUM POLYSTYRENE SULFONATE ORAL SUSPENSION | PHARMEL INC | Suspension | Oral | SODIUM POLYSTYRENE SULFONATE 250 MG | Cancelled Post Market | |
| 02261677 | PHL-SODIUM POLYSTYRENE SULFONATE POWDER | PHARMEL INC | Powder | Oral; Rectal | SODIUM POLYSTYRENE SULFONATE 94.3 MG | Cancelled Post Market | |
| 02261669 | PHL-SODIUM POLYSTYRENE SULFONATE RETENTION ENEMA | PHARMEL INC | Suspension | Rectal | SODIUM POLYSTYRENE SULFONATE 250 MG | Cancelled Post Market | |
| 00769533 | SOLYSTAT | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Suspension | Rectal | SODIUM POLYSTYRENE SULFONATE 250 MG | Cancelled Post Market | |
| 00722456 | SPS SUSPENSION 15GM/60ML | CAROLINA MEDICAL PRODUCTS COMPANY | Suspension | Oral; Rectal | SODIUM POLYSTYRENE SULFONATE 15 G | Cancelled Post Market |
Browse other molecules: